Karachi, AGP Limitedinformed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on August 02, 2018.
The agenda of the meeting was discussion of profit and loss account for quarter ended June 30, 2018 which portrayed a profit of Rs. 284,597,807 with earnings per share 1.02 basic and diluted respectively.
Further, nil payment of cash dividend, bonus shares and right shares was agreed.
AGP Limited (AGP) began its commercial operations in 1989 as an independent pharmaceutical manufacturing company in Karachi, Pakistan. It has steadily grown through manufacturing and marketing products under licensing arrangements with many companies of international repute and also through manufacturing and marketing its own brands. Today, it is one of the largest pharmaceutical companies in Pakistan, providing a broad range of pharmaceutical products. The determination to upgrade the pharmaceutical resources of Pakistan and improvement of the quality of life of a common man was the key motivating factors in the inception of AGP.
The operations of AGP include manufacturing, marketing and sales of pharmaceuticals and healthcare products in the domestic and export market. The delivery of AGP’s products, across the country, is managed by one of the largest and state of art pharmaceutical distribution set ups in Pakistan.